John T. Schiller | |
|---|---|
| Alma mater | University of Wisconsin-Madison,University of Washington in Seattle |
| Awards | Lasker–DeBakey Clinical Medical Research Award (2017) |
| Scientific career | |
| Institutions | National Cancer Institute (NCI) |
| Academic advisors | Douglas R. Lowy |
John T. Schiller is the deputy chief and head of the neoplastic disease section, laboratory of cellular oncology at the U.S.National Cancer Institute (NCI), and an NIH Distinguished Investigator. WithDouglas R. Lowy, he made key contributions topapillomavirus virus molecular biology and the development of theHPV vaccine. Schiller was the recipient of theNational Medal of Technology and Innovation in 2014[1][2] and theLasker-DeBakey Clinical Medical Research Award in 2017.[3]
Schiller earned his B.S. in molecular biology from theUniversity of Wisconsin-Madison in 1975 and his Ph.D. from theUniversity of Washington in Seattle in 1982. He joinedDouglas R. Lowy's Laboratory of Cellular Oncology as aNational Research Service Award postdoctoral fellow in 1983. In 1998, he became the chief of the neoplastic disease section and was designated as an NIH Distinguished Investigator in 2016.[3] He was elected to theNational Academy of Sciences in 2020.[4]
In the early 1990s, Schiller and Lowy worked on the discovery and development of a virus-like particle vaccine of the human papillomavirus. That initial work would ultimately result in the development of the HPV vaccine.[5]
| International | |
|---|---|
| National | |
| Academics | |
